In Q4, Trian Fund added just over 500 shares of GE Aerospace, increasing its total holding to 4.03 million shares with a market value rising from $1.21 billion to approximately $1.24 billion. This move underscores the fund’s confidence in resilient defense and commercial aviation demand, backed by strong order backlogs and ramping engine production.

The fund also marginally increased its position in GE HealthCare by adding 15 shares to bring the total to 4,044 shares, lifting the stake’s market value to around $332,000. Although small, this adjustment signals Trian’s continued interest in the long-term prospects of medical imaging and diagnostic technologies.

At the end of Q4, Trian’s disclosed portfolio value stood at about $3.98 billion across seven holdings, reflecting a concentrated lineup and a strategic shift toward direct buyouts over proxy fights. The incremental moves in GE Aerospace and HealthCare positions highlight a balanced approach between high-growth aerospace assets and medical technology investments.